{"id":"lauroguadine","rwe":[],"tags":[{"label":"lauroguadine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["lauroguadine"],"offLabel":[],"synonyms":["lauroguadine"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"lauroguadine","explanation":"In simple terms, lauroguadine is thought to bind to a particular protein or receptor in the body, which helps to regulate a specific process or function. This binding action triggers a series of downstream effects that ultimately lead to the desired therapeutic outcome.","oneSentence":"Lauroguadine works by interacting with a specific biological target to produce its therapeutic effect.","technicalDetail":"Lauroguadine is a lauroguadine compound that modulates its target through a specific mechanism of action, although the exact details of this process are not well understood."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3315","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LAUROGUADINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T14:04:52.823736","biosimilars":[],"competitors":[],"genericName":"lauroguadine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"J587DZQ8YB","INN_ID":"3350","UMLSCUI":"C2825362","ChEMBL_ID":"CHEMBL1980715","PUBCHEM_CID":"3038489"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"LAUROGUADINE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lauroguadine is a small molecule drug in the lauroguadine class, originally developed by an unknown entity. Its current owner is also unknown. The target and approved indications of lauroguadine are not specified. The commercial status of lauroguadine is unclear, and it is unknown whether it is patented or available as a generic. Further information on its pharmacokinetic properties and safety considerations is also lacking.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}